2013
DOI: 10.1007/978-1-4614-9105-7_2
|View full text |Cite
|
Sign up to set email alerts
|

Recent Progress in Blood–Brain Barrier and Blood–CSF Barrier Transport Research: Pharmaceutical Relevance for Drug Delivery to the Brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 193 publications
0
10
0
Order By: Relevance
“…; Tachikawa et al . ; Nigam et al . ) and an overlap of substrates and differences in expression between species are becoming apparent.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…; Tachikawa et al . ; Nigam et al . ) and an overlap of substrates and differences in expression between species are becoming apparent.…”
Section: Discussionmentioning
confidence: 99%
“…The OATPs (organic ion transporting polypeptides) and OATs (organic ion transporters) act as bidirectional transporters and may therefore be involved in uptake and/or efflux. New members of these families have recently been identified at the BBB (see Sugiyama et al 2003;Tachikawa et al 2014;Nigam et al 2015) and an overlap of substrates and differences in expression between species are becoming apparent.…”
Section: Discussionmentioning
confidence: 99%
“…The blood–brain barrier (BBB), which is formed by brain capillary endothelial cells linked via tight junctions, serves to separate neural tissue from blood. It possesses vectorial transport systems because of polarized expression of various transporter proteins, and these systems regulate the exchange of endogenous and exogenous compounds between brain and blood . Multidrug resistance 1 (MDR1/P‐gp/ABCB1) and breast cancer resistance protein (BCRP/ABCG2), which are representative ATP‐binding cassette (ABC) transporters, are localized at the luminal membrane of the brain capillary endothelial cells in humans and rodents, in accordance with their function to restrict drug entry to the brain .…”
Section: Introductionmentioning
confidence: 99%
“…It possesses vectorial transport systems because of polarized expression of various transporter proteins, and these systems regulate the exchange of endogenous and exogenous compounds between brain and blood. 1,2 Multidrug resistance 1 (MDR1/P-gp/ABCB1) and breast cancer resistance protein (BCRP/ABCG2), which are representative ATP-binding cassette (ABC) transporters, are localized at the luminal membrane of the brain capillary endothelial cells in humans and rodents, in accordance with their function to restrict drug entry to the brain. [3][4][5][6] Amino acid transporter system A2 (ATA2/SLC38A2), a solute carrier (SLC) transporter, is involved in cellular uptake of small neutral amino acids, and is the major subtype of system A at the abluminal membrane in rodents.…”
Section: Introductionmentioning
confidence: 99%
“…The blood-brain barrier (BBB), which consists of brain capillary endothelial cells linked by complex tight junctions, strictly regulates transcellular influx and efflux transport of organic ions, including nutrients and xenobiotics, by means of polarized expression of numerous transporters and receptors (Tachikawa et al, 2014). It has been proposed that dysregulation of BBB transport function exacerbates neuronal damage in the acute stage of ischemic stroke.…”
Section: Introductionmentioning
confidence: 99%